7B023B - Regenerative Medicine: Mechanisms and Translation 01 Sep 2027 - 31 Aug 2033 | Version 0
Associated Module Information
| Module Code: | 7B023B | ||
|---|---|---|---|
| Module Title: | Regenerative Medicine: Mechanisms and Translation | ||
| Faculty: | Faculty of Computing, Engineering and Science | ||
| Faculty Group: | Applied Science | ||
| Faculty Sub Group: | Biology and Chemistry | ||
| Module Leader: | Aled Bryant | ||
| Module Team: | Martin Powell, Andrew Graham | ||
| First Intended Intake: | SEP 2027 | Final Year of Intake: | 2032 |
| Date Closed: | |||
| Credit Value: | 30 | Credit Level: | 7 |
| Language: | English | ||
| Percentage of Module Taught in Welsh: | 33 | ||
| Equivalent Module: | |||
| HECOS codes: | 100572 - tissue engineering and regenerative medicine | ||
| HECOS Code Weighting: | 100 | ||
Document Version Information
| Version | 0 |
|---|---|
| Valid From | 01 Sep 2027 |
| Valid To | 31 Aug 2033 |
Module Aims
The main aims of the module are:
To develop an advanced understanding of stem cell biology, including stem cell classification, self-renewal, differentiation, and the cellular and molecular mechanisms that regulate tissue development and repair.
To develop critical knowledge of current and emerging regenerative medicine approaches, including stem cell therapies, tissue engineering, and gene-editing technologies, and their application in clinical and research settings.
To enable students to evaluate the scientific, ethical, and regulatory challenges associated with translating regenerative medicine technologies from laboratory research to clinical practice.
Content Summary
This module provides an advanced exploration of stem cell biology and regenerative medicine, linking fundamental cellular mechanisms to emerging clinical applications. You will develop a detailed understanding of stem cell classification, self-renewal, differentiation, and the molecular regulation of tissue development and repair. This knowledge will help you understand how biological processes can be applied and manipulated for therapeutic purposes.
The module explores current and developing regenerative medicine approaches, including stem cell therapies, tissue engineering, organoid systems and gene-editing technologies. You will examine how these innovations are being translated into clinical practice to treat degenerative diseases, tissue damage and genetic disorders.
A key feature of the module is its integration of scientific theory with translational and applied perspectives, encouraging interdisciplinary thinking across molecular biology, biotechnology and clinical science. You will critically evaluate the scientific evidence, clinical effectiveness and limitations of regenerative medicine approaches, while also considering the ethical, societal and regulatory issues associated with their development and use.
The module supports the development of advanced analytical, evaluative and research skills relevant to careers in biomedical research, clinical laboratories and biotechnology, while also preparing you for doctoral study in this rapidly evolving field.
Learning and Teaching Methods
| Activity Type | Hours |
|---|---|
| Workshops and practicals / challenge-based learning | 56 |
| Guided study (including 10.5 digital learning) | 15 |
| Self directed study | 139 |
| Formative assessment | 30 |
| Summative assessment | 60 |
| Total Hours Selected | 300 |
Learning Outcomes
| # | Learning Outcome |
|---|---|
| LO1 | Critically evaluate the biological principles and clinical applications of stem cell biology in regenerative medicine, including stem cell sources, differentiation pathways, niche regulation, and the molecular mechanisms underpinning tissue repair and regeneration. |
| LO2 | Analyse and critically appraise current and emerging regenerative medicine strategies, including cell-based therapies, tissue engineering, and gene editing approaches, with consideration of translational challenges relating to safety, efficacy, ethical issues, clinical trial governance, Good Clinical Practice, and regulatory frameworks in clinical application and healthcare practice. |
Module Requisites
| Code | Title | Requisite Type |
|---|---|---|
| MOD014234 | Cellular and Molecular Basis of Disease | pre-requisite |
Assessment Criteria
| Assessment Category | Assessment Type | Description | Duration | Word Count | Weight (%) | Best of? | Pass Mark |
|---|---|---|---|---|---|---|---|
| Synchronous Onsite Oral Assessment | Clinical Viva (Onsite) | Individual: The viva defence further enhances authenticity by assessing students’ ability to justify and defend scientific recommendations under critical questioning, reflecting professional and interdisciplinary biomedical environments. Students must articulate evidence-based arguments, evaluate uncertainties and respond to challenge, demonstrating confidence, leadership, communication and advanced critical thinking | 23 | N/A | 25 | No | 50 |
| Asynchronous Assessment | Case study | Individual Online: The written report directly aligns with the first learning outcome by requiring students to critically evaluate stem cell biology, differentiation pathways and regenerative mechanisms within a clinically relevant scenario. | 0 | 4500 | 75 | No | 50 |
Assessment Matrix
| Assessment Type | Learning Outcomes | ||
|---|---|---|---|
| LO1 | LO2 | ||
| Clinical Viva (Onsite) | ✔ | ✔ | |
| Case study | ✔ | ✔ | |